All In MedTech

Device Trial Radar · NCT06560034

VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements

VicorderCS NIBP Validation Study to Assess Its Ability to Capture Blood Pressure Measurements

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

86

Actual

Start

Aug 15, 2024

Primary completion

Jul 10, 2025

Study completion Jul 14, 2025

Sponsor

Lead sponsor
80 Beats MedicalNot on our public-company list
Sponsor type
Industry
First posted
Aug 19, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

80 Beats Medical introduces the VicorderCS, the next generation of our Vicorder technology designed to manage hypertension and cardiovascular risks. This advanced diagnostic equipment offers non-invasive collection and computation of a plethora of cardiovascular markers. It is faster, easier to use, and more portable than its predecessor, with enhanced connectivity options for extended marker collection and analysis. These markers enable early diagnosis of cardiovascular disease, ensuring positive patient outcomes. With a strong foundation in numerous published clinical studies, the VicorderCS enhances data collection and analysis capabilities, empowering the research community in developing new drugs and therapeutics. This validation study is purposed to evaluate one of the physiological parameters that is measured by the VicorderCS system, which is Non-invasive Blood Pressure (NIBP) via the common oscillometric cuff-based method.

Conditions

  • Cardiovascular Diseases
  • Blood Pressure
  • Hypertension

Interventions

  • VicorderCSDevice

    1. Vascular Sensor (VCS-VAS-1000) measurement device used with accessories (cuffs and tubes) connected to the device; 2. Data Station (VCS-DAT-1000) for data collection and analysis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood PressureTime frame: 1 Day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Manos Health Study Site

    Breckenridge, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.